Want to see CH:CPHN full AI Analyst Report?
CPH Group AG Class A (CPHN) AI Stock Analysis
Top Page
CPH Group AG Class A
(Six Swiss:CPHN)
CPH Group earns a score of 55, reflecting a company in transition that has stabilized after a severe revenue contraction. The most significant factor is the mixed financial performance: while margins and profitability have recovered meaningfully (gross margin at 47.7%, ROE at 11.5%), the business is operating at roughly half its 2022 revenue scale with a diminished equity base. Valuation is fair with a supportive 3.45% dividend yield and a reasonable P/E of 16.9x, providing some downside cushion. Technical indicators are neutral, with the stock trading below its 200-DMA, suggesting the longer-term trend remains cautious. The low beta (0.33) offers defensive qualities but also limits upside participation in broader market rallies. Key risks include the cyclical nature of the industry, uncertain revenue growth prospects, and declining cash flow generation capacity.
CPH Group AG Class A (CPHN) vs. iShares MSCI Switzerland ETF (EWL)
- Market Cap
- CHF 344.12M
- Dividend Yield
- 3.48%
- Average Volume (3M)
- 2,361
- Price to Earnings (P/E)
- 16.7
- Beta (1Y)
- 0.32
- Revenue Growth
- 3.69%
- EPS Growth
- -32.66%
- Country
- Switzerland
- Employees
- 1,249
- Sector
- General
- Sector Strength
- 55
- Industry
- Paper, Lumber & Forest Products
CPH Group AG Class A Business Overview & Revenue Model
Company Description
CPH Chemie + Papier Holding AG, along with its various group entities, focuses on the innovation, manufacture, and commercialization of chemicals, paper for printing, and specialized packaging films for the pharmaceutical sector. The Chemistry segmen...
How the Company Makes Money
CPH Group AG generates revenue primarily through two pillars: (1) its specialty chemicals business and (2) its real estate business. In specialty chemicals, the Zeochem segment sells molecular sieves, chromatography gels, and related adsorbent/proces...
CPH Group AG Class A Financial Statement Overview
Summary
CPH Group shows stabilization after a dramatic revenue contraction (~54% from 2022 peak). Positives include gross margin recovery to 47.7%, net profit margin rebound to 7.0%, improving ROE at 11.5%, and positive free cash flow growth of 60% YoY. However, the massive revenue decline, reduced equity base (CHF 204M vs CHF 436M in 2023), rising debt-to-equity (0.26), and weakening operating cash flow coverage (0.30) temper the outlook. The income statement score of 52, balance sheet score of 58, and cash flow score of 55 collectively reflect a company that is leaner and more profitable but significantly smaller and still navigating cyclical headwinds.
Income Statement
52NeutralBalance Sheet
58NeutralCash Flow
55Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 334.23M | 334.06M | 447.86M | 623.98M | 725.35M | 496.69M |
| Gross Profit | 116.05M | 159.50M | 162.31M | 224.67M | 125.21M | -2.92M |
| EBITDA | 47.16M | 49.06M | 30.90M | 113.06M | 131.09M | -117.87M |
| Net Income | 20.49M | 23.36M | 4.65M | 78.89M | 100.95M | -151.56M |
Balance Sheet | ||||||
| Total Assets | 392.86M | 368.86M | 332.61M | 598.19M | 666.19M | 560.40M |
| Cash, Cash Equivalents and Short-Term Investments | 32.96M | 27.04M | 31.60M | 107.64M | 143.61M | 95.12M |
| Total Debt | 58.40M | 53.23M | 18.94M | 723.00K | 98.85M | 109.82M |
| Total Liabilities | 182.58M | 164.99M | 123.16M | 161.92M | 266.62M | 249.90M |
| Stockholders Equity | 210.27M | 203.50M | 209.45M | 436.27M | 398.21M | 309.13M |
Cash Flow | ||||||
| Free Cash Flow | 30.18M | 12.82M | 22.69M | 75.22M | 63.72M | -8.76M |
| Operating Cash Flow | 50.50M | 34.07M | 45.68M | 109.86M | 97.63M | 15.83M |
| Investing Cash Flow | -33.45M | -50.89M | -46.74M | -18.00M | -29.62M | -19.22M |
| Financing Cash Flow | -10.60M | 13.52M | -75.52M | -125.66M | -18.99M | -17.98M |
CPH Group AG Class A Peers Comparison
Overall Rating
CH:MIKN76Outperform
CH:CPHN55Neutral
CH:BYS55Neutral
CH:MEDX53Neutral
CH:VETN53Neutral
CH:KOMN44Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 76Outperform | CHF 247.26M | 8.99 | 11.74% | 3.97% | -1.24% | -11.13% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 55Neutral | CHF 344.38M | 16.73 | ― | 3.48% | 3.69% | -32.66% | |
| 55Neutral | CHF 318.90M | -7.71 | -7.19% | 2.59% | -1.69% | 30.59% | |
| 53Neutral | CHF 434.08M | 4208.00 | ― | 0.95% | -6.64% | ― | |
| 53Neutral | CHF 363.97M | -102.00 | ― | 2.72% | -4.83% | -139.13% | |
| 44Neutral | CHF 371.22M | -39.56 | ― | ― | -2.66% | 9.28% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CH:CPHN | CPH Group AG Class A | 57.40 | -10.23 | -15.13% | |
| CH:KOMN | Komax Holding | 72.40 | 7.00 | 10.70% | |
| CH:BYS | Bystronic AG | 154.20 | -134.19 | -46.53% | |
| CH:MIKN | Mikron Holding AG | 15.10 | -5.28 | -25.92% | |
| CH:VETN | Vetropack Holding AG Class A | 18.36 | -2.44 | -11.72% | |
| CH:MEDX | medmix AG | 10.52 | 1.62 | 18.19% |
CPH Group AG Class A Corporate Events
CPH Group Lifts Payout Ratio as Packaging Strength Offsets Zeochem Slowdown
CPH Group reported stable first-half 2026 sales of CHF 176 million and EBITDA of CHF 28.3 million, with an improved EBITDA margin of 16.1% back in its target range, supported by cost reductions and a richer product mix at Perlen Packaging. Net profit...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 04, 2026